Background Obesity is associated with increased risk of stillbirth, although the mechanisms are unknown. Obesity is also associated with inflammation. Serum ferritin, C-reactive protein, white blood cell count, and histologic chorioamnionitis are all markers of inflammation. Objective This article determines if inflammatory markers are associated with stillbirth and body mass index (BMI). Additionally, we determined whether inflammatory markers help to explain the known relationship between obesity and stillbirth. Study Design White blood cell count was assessed at admission to labor and delivery, maternal serum for assessment of various biomarkers was collected after study enrollment, and histologic chorioamnionitis was based on placental histology. These markers were compared for stillbirths and live births overall and within categories of BMI using analysis of variance on logarithmic-transformed markers and logistic regression for dichotomous variables. The impact of inflammatory markers on the association of BMI categories with stillbirth status was assessed using crude and adjusted odds ratios (COR and AOR, respectively) from logistic regression models. The interaction of inflammatory markers and BMI categories on stillbirth status was also assessed through logistic regression. Additional logistic regression models were used to determine if the association of maternal serum ferritin with stillbirth is different for
Obesity has been associated with an increased risk of stillbirth (SB), although the mechanism is unknown. 1 Obesity has been described as a state of low-grade chronic inflammation marked by an increase in systemic markers of inflammation. 2 Deregulation of adipocytes results in adipokine and fatty acid release into the circulation and results in immune cell activation. This is believed to be the etiology of obesity-related local and systemic inflammation. 2 Additionally, dysregulated production or secretion of adipokines, which are pro-and anti-inflammatory markers, can contribute to the pathogenesis of obesity-related diseases. Further, obesity-related inflammation has been associated with other pregnancy complications, such as preterm birth, diabetes, and preeclampsia, all of which also have an association with SB. While the underlying basis for the relationship of systemic inflammation with SB is unknown, there is evidence that placental inflammation (histologic chorioamnionitis [HCA] ) is increased in women with SBs. 5 To better understand the relationship of systemic inflammation and SBs, researchers have called for greater assessment of molecular evidence of inflammation that may contribute to SB. 6 The goal of our analysis was to determine if certain inflammatory markers are associated with SB. Additionally, we aimed to determine whether these inflammatory markers help to explain the known relationship between body mass index (BMI) and SB. We evaluated maternal serum ferritin (MSF), serum C-reactive protein (CRP), white blood cell (WBC) count, and HCA. All four markers have been associated with systemic inflammation and inflammatory conditions.
Materials and Methods
The Our analysis included 497 women with singleton SB and 1,414 with a live birth (LB). The analysis is limited to singletons and excludes underweight women, as were those who were incarcerated, and could not give informed consent. Women serving as control subjects in the trial had to be at least 13 years old, live in the catchment area, be identified for enrolment during the hospital stay, and delivered a LB at greater than or equal to 20 weeks' gestational age (GA).
All participants gave written informed consent and were enrolled at the time of delivery. Institutional review boards approved the study at all clinical sites and at the data preterm versus term births. Analyses were weighted for the overall population from which this sample was derived. Results A total of 497 women with singleton stillbirths and 1,414 women with live births were studied with prepregnancy BMI (kg/m 2 ) categorized as normal (18.5- GA determination reflected the best clinical estimate from several sources, which was primarily the first day of the patient's last menstrual period (LMP) verified by ultrasound, dated fully by ultrasound when LMP was unknown, or documentation of the day of ovulation or embryo transfer, when available for pregnancies conceived with assisted reproductive technologies. 7 To ensure inclusion of all possible eligible SBs, fetal deaths at 18 or 19 weeks and without good dating were included in the study. 7 Infants with Appearance, Pulse, Grimace, Activity, and Respiration (APGAR) scores of 0 at 1 and 5 minutes and no signs of life at greater than 20 weeks' gestation were determined to be stillborn. Detailed clinical and demographic information was obtained from medical record abstraction from hospital and clinic records during the antepartum and intrapartum courses, as well as from a standardized maternal interview during the delivery hospitalization. During these interviews, women self-identified their race. BMI was calculated as prepregnancy weight in kilograms divided by height in meters squared as gleaned from chart abstraction or, when not available, from patient interview. Patients enrolled in the study had uniform placental pathology examination performed and a standardized postmortem autopsy was done for SBs. 7 This included specific definitions of pathologic lesions and review of gross specimens (fetus and placenta) and histologic images as determined by pathologists involved in the study to ensure consistent results across sites. Maternal serum was collected at enrollment and stored at -80°C for 2 to 5 years until the MSF and CRP levels were assayed at Associated Regional and University Pathologists, Inc (ARUP) Laboratories, Salt Lake City, Utah. Extreme high values skewed the distributions for these markers. Therefore, the data were analyzed on the natural logarithmic scale (log e ) of the measures and means and 95% confidence intervals (CIs) were back transformed to geometric means with corresponding 95% CIs. WBC count was collected from delivery hospitalization records assessed on the same day as delivery when available; otherwise, results obtained the day prior to delivery were used. If multiple measurements were taken on the same day, the highest measurement for that day was used in the analysis. Elevated WBC count was defined as greater than or equal to 15.0 uL Â 10 3 . 8 HCA was determined from histologic examination for acute chorioamnionitis of either the placental-free membranes or the chorionic plate.
9 Control women were selected from women having an all LB outcome. As such, controls were not enrolled to the study and the blood sample was not taken among consenting women until after delivery. Analysis of variance was used to compare mean levels of MSF and CRP for SB versus LB on the natural logarithmic scale, and logistic regression was used to test for differences in proportions for elevated WBC and HCA. The markers were used in logistic regression models with BMI to study the associations with SB using crude (COR) and adjusted (AOR) odds ratios and corresponding 95% CIs pertaining to BMI. A 10% change or more between the COR and the AOR in either direction was considered important with respect to confounding of the inflammatory marker and BMI in association with SB. Interaction models were used to assess whether associations between inflammatory markers and SB differed by BMI. In addition, MSF levels were categorized using quartile cutoffs for term LBs to further explore the relationship between MSF and BMI in association with SB, and to evaluate whether the associations varied for term versus preterm births.
Analyses were weighted for the study design and differential consent based on characteristics recorded on the screened population. Further, the analysis of chorioamnionitis was weighted to account for differential losses of placental specimens for study protocol examination. Total sample size for both unweighted and weighted samples is provided. Additionally, the analysis is limited to women who had either MSF or CRP results available. Ferritin results, but not other markers, for women who received a blood transfusion were excluded from analysis (n ¼ 67), as we did not collect data on the date and time of blood transfusion.
Results
In our analysis, 497 women with a singleton SB and 1,414 with a LB whose prepregnancy BMI (kg/m 2 ) was normal (18.5-24.9), overweight (25.0-29.9), or obese (30.0 þ ) were included. ►Table 1 describes our study population by maternal BMI and SCRN case status for variables that were previously associated with SB among the SCRN population.
10
More overweight women were black, non-Hispanic and more obese women were Hispanic. More normal weight women were nulliparous compared with overweight and obese women. MSF was further studied with BMI for association with SB, considering differences for term and preterm birth. In this logistic regression analysis, MSF levels were grouped into four categories using the quartiles for term LBs: 2 to 13, 14 to 24, 25 to 41, and 42þ ng/mL. The model included MSF categories, BMI categories, an indicator for preterm birth, and the interaction of MSF and BMI categories with preterm birth. The interaction of MSF with preterm birth was significant (p ¼ 0.0066). This interaction is illustrated in ►Fig. 1. This figure visually illustrates that while BMI did not seem to affect the trend, MSF levels were higher in preterm SBs than in term SBs, where levels were similar across LBs and SBs.
Women who were overweight (COR, 1.48; 95% CI: 1.14-1.94) and obese (COR, 1.60; 95% CI: 1.23-2.08) were more likely than normal weight women to experience SB (►Table 3). When models with SB outcome by BMI were adjusted individually for MSF, CRP, or elevated WBC, these variables had little impact on the OR that associated SB with overweight or obesity. Adjustment for HCA did not Results shown are weighted for study design and differential consent based on characteristics recorded on the screened population. Further, the analysis of HCA is weighted to account for differential losses of placental specimens for study protocol examination. Total sample size is given, unweighted and weighted. Analysis is limited to singletons and excludes underweight women and women missing BMI.
b
Extremely high values skewed the distributions for MSF and CRP. As such, comparisons were made on the natural logarithmic transformation of the measures and the geometric means with corresponding 95% confidence intervals are presented.
substantially change the OR for SB in overweight versus normal weight women. The SB OR for obese versus normal women changed by more than 10% indicating confounding when adjusting for HCA (AOR, 1.38; 95% CI: 1.02-1.88). However, the association of obesity with SB remained significant. BMI by inflammatory marker interaction terms were not significant (did not meet the threshold of p < 0.05) for any of the four markers.
Comment
Obesity has been associated with an increased risk of SB, although the mechanism is unknown. A study of nearly 3,000,000 singleton births using a retrospective cohort of singleton nonanomalous LBs and SBs in Washington and Texas found a SB rate of 3.1 per 1,000 births. 11 In that study, overweight women had a hazard ratio of 10 Nearly 25% of the women with SB between 37 and 42 weeks' gestation were obese.
11
We performed a MEDLINE search that yielded no studies exploring the relationship of MSF, CRP, or leukocytosis to SB. However, HCA has been studied in relationship to SB and a recent analysis of 543 SBs found that HCA was common among women with fetal demise, occurring in a quarter of cases.
12 While MSF is a marker for iron status, it is also a potent marker of systemic inflammation and high levels have been documented in obesity. 13 CRP is a well-known inflammatory marker. 14 CRP is positively associated with BMI;
when BMI is higher, levels of CRP are higher, suggesting again that obesity is a state of systemic low-grade inflammation.
14 Similarly, obesity can be associated with leukocytosis. 15 Finally, a study of over 5,000 women found that obese pregnant women were more likely to have HCA compared with normal weight women. 16 To better understand the relationship between obesity and SB, we evaluated whether these markers of inflammation are more common in obese patients who experience a SB as compared with those with a LB. We found that MSF levels, elevated WBC count, and HCA were positively and CRP levels negatively associated with SB. Among SBs and LBs, CRP levels were elevated in overweight and obese women. CRP levels were negatively associated with SB while obesity is positively associated with SB, a finding we cannot explain. None of the markers studied fully accounted for the relationship between obesity and SB, suggesting that inflammation, as represented by these markers, may not fully explain the relationship between BMI and SB. It is possible that inflammation may play a role in the association of obesity and SB, but the relationship is not mediated by the biomarkers studied; if future studies find additional serum markers of inflammation, these should be further studied in the context of obesity and SB.
Strengths of our study include our analysis of a subset of participants from a large, population-based case-control study with an ethnically, racially, and geographically diverse population. Additionally, we had an accurate estimation of GA at death in SBs, and the ability to examine the contribution of factors affecting the risk of SB. Also, all participants were evaluated with a thorough standardized protocol that minimized variability in data and sample collection.
This study was restricted to singleton pregnancies, which may limit generalizability. Another limitation is the retrospective nature of case-control studies and data derived from maternal interview at the time of delivery.
7 Also, while biomarkers were collected, the measurements were only for the time around delivery and may not reflect exposure at earlier vulnerable periods during gestation. 7 Additionally, the time of data collection, such as when WBC was measured, may have impacted the results. While there is biological plausibility for our hypothesis that the inflammatory state of obesity may explain the relationship between BMI and SB as explored above, our results did not fully explain this relationship. While other markers might help explain the relationship between obesity and SB, markers studied in this analysis suggest that the relationship between obesity and SB is nuanced and not explained by inflammation. It is also possible that any inflammation was elaborated by the SB itself. a Results shown are weighted for study design and differential consent based on characteristics recorded on the screened population. Further, the analysis of HCA is weighted to account for differential losses of placental specimens for study protocol examination. Total sample size is given, unweighted and weighted. Analysis is limited to singletons and excludes underweight women and women missing BMI. b Extremely high values skewed the distributions for MSF and CRP. As such, the measures are included in the adjusted models on the natural logarithmic scale. c Unadjusted odds ratios of SB for overweight versus normal weight women and obese versus normal weight women are provided. These are followed by the adjusted odds ratios for SB for overweight versus normal weight women and obese versus normal weight women individually controlling for the inflammatory markers.
